Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:05 PM
Ignite Modification Date:
2025-12-24 @ 12:05 PM
NCT ID:
NCT00406861
Eligibility Criteria:
Inclusion Criteria:
* MB leprosy
* ENL reaction
* age 15-65
* weight \>35kg
* patient willing to participate,including agrees to investigations and admission
* adequate past records
* no steroid received in past 4 weeks
Exclusion Criteria:
* pregnant or breast feeding
* other active serious infection
* history of intolerance to concerned drug
* known or suspected immunodeficiency
* needs high dose steroid for other condition
* recent new nerve funcion impairment
* recent hepatitis or impaired liver function
* thrombocytopenia, moderate or severe renal impairment
* received high dose clofazimine in past 3 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Maximum Age:
65 Years
Study:
NCT00406861
Study Brief:
Protocol Section:
NCT00406861